Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapy
- 1 November 1996
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 74 (10) , 1655-1659
- https://doi.org/10.1038/bjc.1996.605
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prognostic factors and significance of chemotherapy in patients with recurrent or metastatic transitional cell cancer of the urinary tractCancer, 1994
- CMV chemotherapy for advanced transitional cell carcinomaBritish Journal of Cancer, 1992
- Advanced Bladder Cancer (Stages pT3b, pT4a, pN1 and pN2): Improved Survival after Radical Cystectomy and 3 Adjuvant Cycles of Chemotherapy. Results of a Controlled Prospective StudyJournal of Urology, 1992
- A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.Journal of Clinical Oncology, 1992
- A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.Journal of Clinical Oncology, 1990
- New Combination Chemotherapy Programme for Bladder CancerBritish Journal of Urology, 1989
- Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the UrotheliumNew England Journal of Medicine, 1988
- Combination Chemotherapy with Cisplatin and Methotrexate in Advanced Transitional Cell Cancer of the BladderJournal of Urology, 1987
- Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.Journal of Clinical Oncology, 1985
- Reporting results of cancer treatmentCancer, 1981